Obalon Therapeutics Inc

NASDAQ:OBLN   3:59:43 PM EDT
2.37
-0.02 (-0.84%)
Earnings Announcements

Obalon Therapeutics Reports Q4 Loss Per Share Of $0.17

Published: 03/12/2021 21:38 GMT
Obalon Therapeutics Inc (OBLN) - Q4 Loss per Share $0.17.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be $0.00

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.